Imprinting equips the immune system with a memory of an invader that helps it prepare to do battle again. The key players are memory B-cells which are generated in lymph nodes during the body's first exposure to a virus. These cells then keep watch in the bloodstream for the same foe, ready to develop into plasma cells that then churn out antibodies. Imprinting was first observed in 1947 by Jonas Sulk and Thomas Francis, the developers of the first flu vaccine - together with another scientist, Joseph Quilligan. They found people who had previously had flu and were then vaccinated against the current circulating strain produced antibodies against the first strain they had encountered. This gave the phenomenon the
Imprinting is a quirk of the immune system in which someone’s initial exposure to a virus biases their immune response when they meet the same virus again.
Studies are showing how imprinting shapes people’s responses to SARS-CoV-2; those infected with earlier strains can mount weaker responses to a later Omicron infection.
This phenomenon is dampening the hope that variant-tailored boosters will markedly reduce transmission of the virus, although researchers agree that variant-tailored boosters are worth getting because they still provide some immunity, and prevent serious illness.
This is an audio version of our Feature: How your first brush with COVID warps your immunity
Hosted on Acast. See acast.com/privacy for more information.